Citigroup
YARW

Citigroup’s Yarrow Bioscience YARW Stock Holding History

Citigroup’s Portfolio YARW Stock Details YARW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.22K Buy
+232
New +$7.9K ﹤0.01% 5358
2022
Q3 		– Sell
-44
Closed -$16K – 6360
2022
Q2 		$16K Buy
44
+43
+4,300% +$18K ﹤0.01% 5133
2022
Q1 		$1K Buy
+1
New +$594 ﹤0.01% 6224
2021
Q4 		– Sell
-3
Closed -$4K – 6111
2021
Q3 		$4K Hold
3
– – ﹤0.01% 5619
2021
Q2 		$11K Sell
3
-163
-98% -$645K ﹤0.01% 5635
2021
Q1 		$1.02M Buy
166
+157
+1,744% +$1.14M ﹤0.01% 2971
2020
Q4 		$52K Buy
9
+7
+350% +$44K ﹤0.01% 6018
2020
Q3 		$12K Sell
2
-2
-50% -$11.7K ﹤0.01% 6519
2020
Q2 		$25K Hold
4
– – ﹤0.01% 6455
2020
Q1 		$40K Buy
4
+3
+300% +$47.1K ﹤0.01% 6182
2019
Q4 		$17K Buy
+1
New +$16.7K ﹤0.01% 7002
2019
Q3 		– Sell
-1
Closed -$16.1K – 7229
2019
Q2 		$24K Hold
1
– – ﹤0.01% 6998
2019
Q1 		$19K Hold
1
– – ﹤0.01% 6996
2018
Q4 		$10K Hold
1
– – ﹤0.01% 7163
2018
Q3 		$26K Buy
+1
New +$30.9K ﹤0.01% 6963
2018
Q2 		– Hold
0
– – – 7198
2018
Q1 		– Hold
0
– – – 6469

Other funds holding YARW

US Bancorp
US Bancorp Minneapolis, Minnesota $92B AUM 22.91% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
MB, Levis & Associates
MB, Levis & Associates Center Valley, Pennsylvania $273M AUM 8.08% 1-Year Est. Return
Hurley Capital
Hurley Capital New York $206M AUM 18.12% 1-Year Est. Return

Citigroup's YARW Position: Q3 2026 in Review

Citigroup opened a new position in Yarrow Bioscience (YARW) in Q3 2026: 232 shares worth $5.22K. The stake represents ﹤0.01% of the portfolio and ranks #5358 among its holdings. This is a return to the name: Citigroup previously reported a position in YARW as recently as Q2 2022.

Citigroup first reported a position in YARW in Q3 2018 and has held it in 15 quarters since. The position peaked at $1.02M in Q1 2021. 6 funds tracked by Wall St. Rank hold YARW as of Q3 2026.

  • Citigroup held 232 shares of Yarrow Bioscience worth $5.22K as of Q3 2026.
  • Yarrow Bioscience was a new Citigroup position in Q3 2026.
  • Yarrow Bioscience made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #5358 holding.
  • Citigroup first reported a position in Yarrow Bioscience in Q3 2018 and has held it in 15 quarters since.
  • Citigroup's Yarrow Bioscience position peaked at $1.02M in Q1 2021.
  • 6 funds tracked by Wall St. Rank held Yarrow Bioscience as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.